JMP Securities
Healthcare Focus Conference
October 6 - 7, 2008
Le Parker Meridien, New York, NY
| Monday, October 6, 2008 |
| Time (ET) |
Azekka |
Tansa |
Mirus |
| 8:30 a.m. |
Alexza Pharmaceuticals, Inc. |
Somaxon Pharmaceuticals, Inc. |
A.D.A.M., Inc. |
| 9:00 a.m. |
Poniard Pharmaceuticals, Inc. |
Idera Pharmaceuticals, Inc. |
C. R. Bard, Inc. |
| 9:30 a.m. |
Perrigo Company |
Vertex Pharmaceuticals Incorporated |
AtriCure, Inc. |
| 10:00 a.m. |
Orexigen Therapeutics, Inc. |
Pharmasset, Inc. |
BioCryst Pharmaceuticals, Inc. |
| 10:30 a.m. |
Neuromed Pharmaceuticals Ltd. |
Human Genome Sciences, Inc. |
Micrus Endovascular Corporation |
| 11:00 a.m. |
Indevus Pharmaceuticals, Inc. |
Incyte Corporation |
Eclipsys Corp. |
| 11:30 a.m. |
Sangamo BioSciences, Inc. |
Exelixis, Inc. |
PharMerica Corp. |
| 12:00 p.m. |
Allos Therapeutics, Inc. |
S*BIO Pte Ltd. |
Given Imaging Ltd. |
| 12:30 p.m. |
EyeGate Pharmaceuticals, Inc. |
TargeGen, Inc. |
Celleration |
| 1:00 p.m. |
ACADIA Pharmaceuticals Inc. |
“JAK Under the Microscope: Implications for the Treatment of
Disease”
— Panel Hosted by Liisa Bayko,
Senior Research Analyst |
Chem Rx |
| 1:30 p.m. |
Cadence Pharmaceuticals, Inc. |
DiagnoCure Inc. |
| 2:00 p.m. |
Vascular Biogenics Ltd. |
InterMune, Inc. |
American Care Source Holdings, Inc. |
| 2:30 p.m. |
XDx, Inc. |
ViroPharma Incorporated |
NxStage Medical, Inc. |
| 3:00 p.m. |
Arca Biopharma Inc. |
ImmunoGen, Inc. |
Dialysis Corporation of America |
| 3:30 p.m. |
ZIOPHARM Oncology, Inc. |
Presidio Pharmaceuticals, Inc. |
Isolagen, Inc. |
| 4:00 p.m. |
Concert Pharmaceuticals, Inc. |
Idenix Pharmaceuticals, Inc. |
STARLIMS Technologies Ltd. |
| 4:30 p.m. |
Transcept Pharmaceuticals, Inc. |
Vitae Pharmaceuticals, Inc. |
AVI BioPharma, Inc. |
| Tuesday, October 7, 2008 |
| Time (ET) |
Azekka |
Tansa |
Mirus |
| 8:30 a.m. |
Monogram Biosciences, Inc. |
Rigel Pharmaceuticals, Inc. |
Allscripts Healthcare Solutions Inc. |
| 9:00 a.m. |
Osiris Therapeutics, Inc. |
Achillion Pharmaceuticals, Inc. |
Horizon Therapeutics |
| 9:30 a.m. |
Cytokinetics, Incorporated |
athenahealth Inc. |
Insulet Corporation |
| 10:00 a.m. |
Genomic Health, Inc. |
Spectrum Pharmaceuticals, Inc. |
Echo Therapeutics |
| 10:30 a.m. |
Celgene Corporation |
Quality Systems Inc. |
DexCom, Inc. |
| 11:00 a.m. |
Myriad Genetics, Inc. |
Synta Pharmaceuticals Corp. |
“Emerging Diabetes Technologies: Barriers to Adoption”
— Panel Hosted by Mimi Pham,
Senior Research Analyst |
| 11:30 a.m. |
Celera Corporation |
SXC Health Solutions Corp. |
| 12:00 p.m. |
“High Value Molecular Dx Tests and the Emerging Paradigm in Breast Cancer Diagnosis and Treatment”
— Panel Hosted by Charles Duncan,
Ph.D, Senior Research Analyst |
Javelin Pharmaceuticals, Inc. |
Endocare Inc. |
| 12:30 p.m. |
Inverness Medical Innovations, Inc. |
LeMaitre Vascular, Inc. |
| 1:00 p.m. |
Pharmaxis Ltd. |
Cerus Corporation |
Integra Lifesciences Holdings Corporation |
| 1:30 p.m. |
Alnylam Pharmaceuticals, Inc. |
Enanta Pharmaceuticals, Inc. |
HeartWare Limited |
| 2:00 p.m. |
Acceleron Pharma, Inc. |
Ardea Biosciences, Inc. |
Novadaq Technologies Inc. |
| 2:30 p.m. |
Cypress Bioscience, Inc. |
PTC Therapeutics |
HydroCision, Inc. |
| 3:00 p.m. |
Corcept Therapeutics Incorporated |
Anadys Pharmaceuticals, Inc. |
AVEO Pharmaceuticals, Inc. |
|
|
|
